1. Home
  2. FTK vs ELDN Comparison

FTK vs ELDN Comparison

Compare FTK & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTK
  • ELDN
  • Stock Information
  • Founded
  • FTK 1985
  • ELDN 2004
  • Country
  • FTK United States
  • ELDN United States
  • Employees
  • FTK N/A
  • ELDN N/A
  • Industry
  • FTK Major Chemicals
  • ELDN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTK Industrials
  • ELDN Health Care
  • Exchange
  • FTK Nasdaq
  • ELDN Nasdaq
  • Market Cap
  • FTK 212.1M
  • ELDN 178.4M
  • IPO Year
  • FTK N/A
  • ELDN N/A
  • Fundamental
  • Price
  • FTK $15.64
  • ELDN $2.87
  • Analyst Decision
  • FTK Strong Buy
  • ELDN Strong Buy
  • Analyst Count
  • FTK 1
  • ELDN 1
  • Target Price
  • FTK $8.00
  • ELDN $16.00
  • AVG Volume (30 Days)
  • FTK 457.5K
  • ELDN 173.9K
  • Earning Date
  • FTK 05-06-2025
  • ELDN 05-14-2025
  • Dividend Yield
  • FTK N/A
  • ELDN N/A
  • EPS Growth
  • FTK 683.07
  • ELDN N/A
  • EPS
  • FTK 0.46
  • ELDN N/A
  • Revenue
  • FTK $202,013,000.00
  • ELDN N/A
  • Revenue This Year
  • FTK $9.41
  • ELDN N/A
  • Revenue Next Year
  • FTK $9.25
  • ELDN N/A
  • P/E Ratio
  • FTK $33.91
  • ELDN N/A
  • Revenue Growth
  • FTK 11.96
  • ELDN N/A
  • 52 Week Low
  • FTK $3.30
  • ELDN $2.00
  • 52 Week High
  • FTK $11.42
  • ELDN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • FTK 88.83
  • ELDN 41.53
  • Support Level
  • FTK $7.01
  • ELDN $2.82
  • Resistance Level
  • FTK $15.72
  • ELDN $3.16
  • Average True Range (ATR)
  • FTK 1.07
  • ELDN 0.27
  • MACD
  • FTK 0.87
  • ELDN -0.02
  • Stochastic Oscillator
  • FTK 96.76
  • ELDN 7.25

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: